Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of S-877503 (guanfacine) in Adult Patients with ADHD
jRCT2080223176Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing S-877503 (guanfacine) with Placebo (2 arms). Started Apr 2016; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on jRCT2080223176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223176.